Get started
Author

Khashayar Roshanzamir

ORCID: 0009-0005-9426-5433
Observed ORCID: 0009-0005-9426-5433
OpenAlex ID: A5043300475
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations
2022 · Payam Tabarsi, Nassim Anjidani, et al. · Clinical Microbiology and Infection · 51
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial
2022 · Payam Tabarsi, Nassim Anjidani, et al. · Immunology · 39
PDF
Evaluation of the Physicochemical and Biological Stability of Cetuximab under Various Stress Condition
2019 · Afsaneh Farjami, Mohammadreza Siahi-Shadbad, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 24
PDF
Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial
2023 · Payam Tabarsi, Setareh Mamishi, et al. · International Immunopharmacology · 7
Aurones as New Porcine Pancreatic α-Amylase Inhibitors
2018 · Khashayar Roshanzamir, Elaheh Kashani-Amin, et al. · Letters in Drug Design & Discovery · 4
Optimization of Culture Conditions to Improve Follicle-Stimulating Hormone Production by CHO-DG44 Cells in Serum-Free Medium
2024 · Hanna Ghobadian, Khashayar Roshanzamir, et al. · ̒Ulūm va funūn-i bastah/bandī · 3
PDF
Local Delivery of Interferon‐β1a for Respiratory Viral Infections: A Systematic Review
2026 · Mahsa Nayebhashemi, Mandana Akhavan, et al. · Reviews in Medical Virology
PDF
Works count: 7
Citation count: 128
H-index: 4
I10-index: 3
Year
Topic
Type